Catalyst Wire Dossier Catalyst Wire Dossier

TriAlign Percutaneous Tricuspid Valve Annuloplasty System

· Mitralign, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TriAlign Percutaneous Tricuspid Valve Annuloplasty System, covering 2017-10-27 to 2017-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. [NA]

See pricing